Coherus Oncology Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.14

+0.05 (+2.39%)

As of Feb 8, 2:01 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +1,591.6% upside

Low Target $24.75

Average Target $36.20

High Target $54.95

Current Price $2.14

Current
$2.14

Target
$36.20

$24.75 $36.20 avg $54.95

Scenario Analysis

Bear Case

$24.75

1,056.5%

Low target

Base Case

$36.20

+1,591.6%

Avg target

Bull Case

$54.95

+2,467.8%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$44.36

-95.2% from high

52-Week Low

$19.01

+-88.7% from low

Target vs 52W High

$36.20

-18.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%